Previous Close | 0.1800 |
Open | 0.1800 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 27.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.1800 - 0.1800 |
Contract Range | N/A |
Volume | |
Open Interest | 83 |
Key Insights Using the 2 Stage Free Cash Flow to Equity, Myriad Genetics fair value estimate is US$34.23 Current share...
Myriad Genetics (MYGN) collaborates with GSK to improve access to HRD diagnostic testing for HGSOC patients.
Myriad Genetics (MYGN) continues to enhance its customer targeting, digital marketing and overall operating model to drive commercial leverage in 2024 and beyond.